Skip to main content

Lysine Acylation Peptides

Services & Products


Get published in Nature

LifeTein Referral Rewards Program

Lysine Acylation Peptides

Acetylation was for a long time the only acyl mark anyone looked for on a lysine. It is no longer alone. Alongside acetylation, eight further short-chain lysine acylations have been established as histone modifications — propionylation, butyrylation, 2-hydroxyisobutyrylation, succinylation, malonylation, glutarylation, crotonylation and β-hydroxybutyrylation — each regulated by enzymatic and metabolic mechanisms and each with physiological functions of its own.1 Lactylation was added to the list in 2019.2

What makes the series interesting is where the acyl groups come from. The donors are acyl-CoA species drawn from central metabolism — crotonyl-CoA, succinyl-CoA, lactoyl-CoA — so the acylation state of chromatin reflects the metabolic state of the cell, and the modifications act as a route by which metabolism reaches gene expression.1

We make peptides carrying any of these marks at a defined position. Below is what each one weighs, where the analytical traps are, and what we need from you to build one.

Diagram of a lysine side chain acylated on its epsilon-amino nitrogen, with a table of ten short-chain acyl groups grouped as simple alkyl, unsaturated, hydroxy and acidic, each with chemical formula and monoisotopic mass shift, and a note on the isobaric species at nominal mass 86.
Every one of these marks sits on the same atom: the ε-amino nitrogen of a lysine side chain. What differs is the acyl group, and with it the charge, the bulk and the mass. Acetylation, propionylation and butyrylation simply lengthen an alkyl chain; crotonylation introduces a rigid α,β-unsaturated bond; malonylation, succinylation and glutarylation each add a carboxylate, which reverses the residue’s charge from positive to negative.

Why a synthetic peptide, and not an antibody alone

Most work on these marks is done with antibodies, and antibody quality in this field has a documented history of trouble. A survey of more than 200 antibodies raised against 57 histone modifications found that over a quarter failed specificity testing by dot blot or western blot, and that among those that did pass, more than a fifth failed in chromatin immunoprecipitation.3 A later peptide-microarray study of more than 100 commercial histone antibodies made the same point in more detail and put the results in a public database.4

The reason is structural rather than careless manufacturing. The chemical differences between these marks are small, and the sequence around them is often repetitive — H3K9 and H3K27 both sit in an identical ARKS motif, so an antibody has to read the residues outside that motif to tell the two sites apart.5 Add the near-isobaric pairs in the figure above and it becomes clear why an antibody raised against one acylation may also report a different one.

A synthetic peptide carrying one mark at one known position is the control that settles it. Peptide arrays are the established format for profiling histone antibody specificity,4 and the same peptides serve as blocking competitors, as binding partners for reader-domain pull-downs, and as standards that fix retention time and fragmentation behaviour in a mass spectrometry method.

What we supply

ClassModificationsTypical use
Simple alkyl Acetyl, propionyl, butyryl, isobutyryl, hexanoyl Reader-domain binding, HDAC and sirtuin substrate work
Unsaturated Crotonyl YEATS and bromodomain binding, antibody validation
Hydroxy 2-Hydroxyisobutyryl, R- and S-3-hydroxybutyryl, lactyl Metabolic chromatin studies, MS standards
Acidic Malonyl, succinyl, glutaryl Charge-reversal studies, sirtuin assays
Aromatic and other Nicotinyl, isonicotinyl, benzoyl, dopaminyl, serotonyl Less common marks, usually as antibody controls
Methylation Mono-, di- and tri-methyl lysine; symmetric and asymmetric dimethyl arginine Frequently ordered alongside acylations on the same sequence

All of these can be combined with the formats that make a peptide usable in an assay: an N-terminal or C-terminal biotin for array printing and pull-down, a spacer between the biotin and the sequence, a fluorescent label, or a free versus capped terminus. See the full catalog entry for the complete list of building blocks.

Specifying the order

Four things decide whether the peptide you receive is the one your experiment needs:

  • The exact residue. Give the position, not just the mark — H3K9cr rather than “crotonylated H3”.
  • Enough sequence context. If the antibody or reader has to discriminate between sites in a repeated motif, the peptide must be long enough to contain what distinguishes them.
  • Terminal chemistry. A free N-terminus is itself a strong epitope; capping it changes what an antibody sees.
  • The handle. Say whether you need biotin, where it goes, and whether a spacer is wanted between it and the sequence.

Where a project calls for a set — one mark per peptide across a panel, or the same mark walked along a sequence — we build them together so that they share purification and analysis conditions.

Confirming the mark by mass

The mass shifts in the figure are monoisotopic and additive, so a peptide carrying two marks shows the sum. Two cases need care, and both are visible in the table above: 2-hydroxyisobutyryl and β-hydroxybutyryl are exact isomers, identical in formula and mass, separable only by retention time or fragmentation; and malonyl sits 0.0364 Da away from both, which is within reach of a high-resolution instrument but not of a modest one.

The same 0.0364 Da gap separates trimethylation from acetylation, which is the better-known version of the same trap. Our modification mass table covers that pair and the other common near-coincidences.

Tell us the mark and the position. Send the sequence with the modification written in, and say what the peptide is for — an array, a pull-down, an MS standard. If a different format would serve the experiment better, we will say so before quoting. We send a quote within 24 hours.

Request a Quote

Related pages

References

  1. Sabari BR, Zhang D, Allis CD, Zhao Y. Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol. 2017;18(2):90–101. doi:10.1038/nrm.2016.140
  2. Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575–580. doi:10.1038/s41586-019-1678-1
  3. Egelhofer TA, Minoda A, Klugman S, et al. An assessment of histone-modification antibody quality. Nat Struct Mol Biol. 2011;18(1):91–93. doi:10.1038/nsmb.1972
  4. Rothbart SB, Dickson BM, Raab JR, et al. An interactive database for the assessment of histone antibody specificity. Mol Cell. 2015;59(3):502–511. doi:10.1016/j.molcel.2015.06.022
  5. Kungulovski G, Jeltsch A. Quality of histone modification antibodies undermines chromatin biology research. F1000Research. 2015;4:1160. doi:10.12688/f1000research.7265.2

All LifeTein products are supplied for laboratory research use only. They are not for human or veterinary use, and not for diagnostic or therapeutic use.